Heron Therapeutics Set to Share Q2 2025 Results Soon
Heron Therapeutics Announces Financial Results Conference Call
Heron Therapeutics, Inc. (NASDAQ: HRTX), a notable player in the biotechnology field, is preparing for its upcoming announcement of financial results for the second quarter of 2025. The excitement within the company is palpable as they gear up for a detailed conference call scheduled for Monday, August 11, 2025, at 4:30 p.m. ET. This call is set to present an overview of their financial performance and explore the latest developments within the organization.
How to Join the Conference Call
For those interested in joining, Heron Therapeutics is providing a convenient registration link which attendees can utilize to access the call. The company encourages all participants to join at least 15 minutes early to ensure a smooth connection, allowing everyone to be fully engaged as the discussion unfolds.
Webcast Availability
In addition to the phone access, the conference call will also be streamed live on Heron's official website under the Investor Relations section. Following the event, a recorded archive of the session will be available on the same platform for 60 days, ensuring that everyone has the opportunity to catch up on what they may have missed.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. stands at the forefront of biotechnological innovation, focused on enhancing treatment options for patients. Their mission is rooted in developing and commercializing advanced therapeutic solutions that significantly improve patient care. With a foundation of cutting-edge science and patented technologies, Heron strives to elevate the standard-of-care particularly in acute care and oncology settings.
Innovations in Drug Development
Heron’s unique approach in drug discovery and development allows them to maintain a strong portfolio of products designed to make a meaningful impact in the lives of patients. Through relentless dedication to research and development, the organization aims to continue its journey of advancements in healthcare solutions.
Investor Relations Contact
For inquiries regarding investor relations, interested parties are encouraged to reach out to Ira Duarte, the Executive Vice President and Chief Financial Officer at Heron Therapeutics, Inc. You can connect with Ira directly by calling 858-251-4400. Heron remains committed to transparency, ensuring that stakeholders are kept informed about company progress and financial standing.
Frequently Asked Questions
1. When will Heron Therapeutics report their financial results?
Heron Therapeutics will report its financial results for Q2 2025 on Monday, August 11, 2025, at 4:30 p.m. ET.
2. How can I access the conference call?
Participants can access the conference call through a registration link provided by Heron Therapeutics, which will include dial-in details.
3. Will there be a webcast available for the call?
Yes, the conference call will also be available as a live webcast on Heron's official website.
4. How long will the call archive be available?
The archive of the teleconference will be accessible for 60 days following the call on Heron's website.
5. Who is the media contact for Heron Therapeutics?
The media contact is Ira Duarte, the Executive Vice President and Chief Financial Officer. You can contact him through the company’s main line.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.